4.6 Article

Outcomes of Extended-Hours Hemodialysis Performed Predominantly at Home

Journal

AMERICAN JOURNAL OF KIDNEY DISEASES
Volume 61, Issue 2, Pages 247-253

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2012.08.032

Keywords

End-stage kidney disease; extended-hours hemodialysis; mortality; technique failure; vascular access events

Funding

  1. Australian Postgraduate Award
  2. Australasian Kidney Trials Network
  3. Royal Australasian College of Physicians Jacquot Research Establishment Award
  4. Royal Australasian College of Physicians Jacquot Fellowship
  5. Australian National Health and Medical Research Council Principal Research Fellowship
  6. Heart Foundation/Office of Science and Medical Research (NSW) Career Development Award
  7. Baxter
  8. Servier
  9. Gambro
  10. Amgen
  11. Johnson and Johnson
  12. Novartis
  13. Roche
  14. Abbott
  15. AstraZeneca

Ask authors/readers for more resources

Background: Recent evidence suggests that increased frequency and/or duration of dialysis are associated with improved outcomes. We aimed to describe the outcomes associated with patients starting extended-hours hemodialysis and assess for risk factors for these outcomes. Study Design: Case series. Setting & Participants: Patients were from 6 Australian centers offering extended-hours hemodialysis. Cases were patients who started treatment for 24 hours per week or longer at any time. Outcomes: All-cause mortality, technique failure (withdrawal from extended-hours hemodialysis therapy), and access-related events. Measurements: Baseline patient characteristics (sex, primary cause of end-stage kidney disease, age, ethnicity, diabetes, and cannulation technique), presence of a vascular access-related event, and dialysis frequency. Results: 286 patients receiving extended-hours hemodialysis were identified, most of whom performed home (96%) or nocturnal (77%) hemodialysis. Most patients performed alternate-daily dialysis (52%). Patient survival rates using an intention-to-treat approach at 1, 3, and 5 years were 98%, 92%, and 83%, respectively. Of 24 deaths overall, cardiac death (n = 7) and sepsis (n = 5) were the leading causes. Technique survival rates at 1, 3, and 5 years were 90%, 77%, and 68%, respectively. Access event-free rates at the same times were 80%, 68%, and 61%, respectively. Access events significantly predicted death (HR, 2.85; 95% CI, 1.14-7.15) and technique failure (HR, 3.76; 95% CI, 1.93-7.35). Patients with glomerulonephritis had a reduced risk of technique failure (HR, 0.31; 95% CI, 0.14-0.69). Higher dialysis frequency was associated with elevated risk of developing an access event (HR per dialysis session, 1.56; 95% CI, 1.03-2.36). Limitations: Selection bias, lack of a comparator group. Conclusions: Extended-hours hemodialysis is associated with excellent survival rates and is an effective treatment option for a select group of patients. The major treatment-associated adverse events were related to complications of vascular access, particularly infection. The risk of developing vascular access complications may be increased in extended-hours hemodialysis, which may negatively affect long-term outcomes. Am J Kidney Dis. 61(2):247-253. (c) 2013 by the National Kidney Foundation, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available